Anthony B. Evnin, Director at INFINITY PHARMACEUTICALS, INC. (INFI), sold 163,864 shares at $15.40 ($2.4M) on 2013-11-25, disclosed to the SEC on 2013-11-27.
Open-market sale of $2.4M INFI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.40 | 23,703 | $365K | 15.0% |
| 2 | $14.72 | 138,961 | $2.0M | 84.2% |
| 3 | $14.56 | 1,200 | $17K | 0.7% |
| Total | $14.82 avg | 163,864 | $2.4M | 100% |
| Filing → |
| CNST | BUY | 2019-10-04 | $48.0M | — | Filing → |
| AVEO | BUY | 2018-11-26 | $223 | — | Filing → |
| AVEO | SELL | 2018-11-16 | $4.3M | — | Filing → |